A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation

Matrix Biology

Volumn 27, Issue 2, 2008, Pages 150-160

  Farach Carson, Mary C ^a   Brown, Anissa J ^a   Lynam, Megan ^a   Safran, Jeffrey B ^a   Carson, Daniel D ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Cell adhesion; Extracellular matrix; Heparan sulfate proteoglycan; Immunoglobulin repeat; Peptide; Perlecan

Indexed keywords

ACTIN; FOCAL ADHESION KINASE; IMMUNOGLOBULIN G; PERLECAN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BIOINFORMATICS; CELL ADHESION; CELL SPREADING; CELL SURFACE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIGENS, CD29; CATIONS, DIVALENT; CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; COMPUTATIONAL BIOLOGY; CYTOSKELETON; ENZYME ACTIVATION; FIBROBLASTS; FOCAL ADHESION KINASE 1; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HUMANS; HYDROPHOBICITY; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; SERUM ALBUMIN, BOVINE;

EID: 38949207947     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2007.09.007     Document Type: Article

References (41)

1. Arikawa-Hirasawa E., Watanabe H., Takami H., Hassell J.R., and Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23 (1999) 354-358
2. Arikawa-Hirasawa E., Wilcox W.R., Le A.H., Silverman N., Govindraj P., Hassell J.R., and Yamada Y. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nat. Genet. 27 (2001) 431-434
3. Balasubramani M., Bier M.E., Hummel S., Schneider W.J., and Halfter W. Perlecan and its immunoglobulin like domain IV are abundant in vitreous and serum of the chick embryo. Matrix. Biol. 23 (2004) 143-152
4. Booyens J., Engelbrecht P., le Roux S., Louwrens C.C., Van der Merwe C.F., and Katzeff I.E. Some effects of the essential fatty acids linoleic acid and alpha-linolenic acid and of their metabolites gamma-linolenic acid, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, and of prostaglandins A1 and E1 on the proliferation of human osteogenic sarcoma cells in culture. Prostaglandins Leukot. Med. 15 (1984) 15-33
5. Brown J.C., Sasaki T., Gohring W., Yamada Y., and Timpl R. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans. Eur. J. Biochem. 250 (1997) 39-46
6. Chakravarty S., Horchar T., Jefferson B., Laurie G.W., and Hassell J.R. Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence. J. Biol. Chem. 270 (1995) 404-409
7. Costell M., Gustafsson E., Aszodi A., Morgelin M., Bloch W., Hunziker E., Addicks K., Timpl R., and Fassler R. Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell. Biol. 147 (1999) 1109-1122
8. Desai N.N., Kennard E.A., Kniss D.A., and Friedman C.I. Novel human endometrial cell line promotes blastocyst development. Fertil. Steril. 61 (1994) 760-766
9. Dolan M., Horchar T., Rigatti B., and Hassell J.R. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. J. Biol. Chem. 272 (1997) 4316-4322
10. Farach-Carson M.C., and Carson D.D. Perlecan: a multifunctional extracellular proteoglycan scaffold. Glycobiology 17 (2007) 897-905
11. Farach-Carson M.C., Hecht J.T., and Carson D.D. Heparan sulfate proteoglycans: key players in cartilage biology. Crit. Rev. Eukaryot. Gene. Expr. 15 (2005) 29-48
12. French M.M., Smith S.E., Akanbi K., Sanford T., Hecht J., Farach-Carson M.C., and Carson D.D. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J. Cell. Biol. 145 (1999) 1103-1115
13. French M.M., Gomes Jr. R.R., Timpl R., Hook M., Czymmek K., Farach-Carson M.C., and Carson D.D. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. J. Bone. Miner. Res. 17 (2002) 48-55
14. Friedrich M.V., Gohring W., Morgelin M., Brancaccio A., David G., and Timpl R. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V. J. Mol. Biol. 294 (1999) 259-270
15. Gumbiner B.M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84 (1996) 345-357
16. Hassell J., Yamada Y., and Arikawa-Hirasawa E. Role of perlecan in skeletal development and diseases. Glycoconj. J. 19 (2002) 263-267
17. Hayashi K., Madri J.A., and Yurchenco P.D. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan. J. Cell. Biol. 119 (1992) 945-959
18. Heino J. The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix. Biol. 19 (2000) 319-323
19. Hopf M., Gohring W., Kohfeldt E., Yamada Y., and Timpl R. Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin. Eur. J. Biochem. 259 (1999) 917-925
20. Hopf M., Gohring W., Mann K., and Timpl R. Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan. J. Mol. Biol. 311 (2001) 529-541
21. Iozzo R.V. Basement membrane proteoglycans: from cellar to ceiling. Nat. Rev. Mol. Cell. Biol. 6 (2005) 646-656
22. Laplante P., Raymond M.A., Labelle A., Abe J., Iozzo R.V., and Hebert M.J. Perlecan proteolysis induces an alpha2beta1 integrin- and Src family kinase-dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation. J. Biol. Chem. 281 (2006) 30383-30392
23. Matlin K.S., Haus B., and Zuk A. Integrins in epithelial cell polarity: using antibodies to analyze adhesive function and morphogenesis. Methods 30 (2003) 235-246
24. Murdoch A.D., Dodge G.R., Cohen I., Tuan R.S., and Iozzo R.V. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem. 267 (1992) 8544-8557
25. Newton J.P., Buckley C.D., Jones E.Y., and Simmons D.L. Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J. Biol. Chem. 272 (1997) 20555-20563
26. Nicole S., Davoine C.S., Topaloglu H., Cattolico L., Barral D., Beighton P., Hamida C.B., Hammouda H., Cruaud C., White P.S., Samson D., Urtizberea J.A., Lehmann-Horn F., Weissenbach J., Hentati F., and Fontaine B. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat. Genet. 26 (2000) 480-483
27. Noonan D.M., Fulle A., Valente P., Cai S., Horigan E., Sasaki M., Yamada Y., and Hassell J.R. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem. 266 (1991) 22939-22947
28. Oda O., Shinzato T., Ohbayashi K., Takai I., Kunimatsu M., Maeda K., and Yamanaka N. Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. Clin. Chim. Acta. 255 (1996) 119-132
29. Olsen B.R. Life without perlecan has its problems. J. Cell. Biol. 147 (1999) 909-911
30. Raymond M.A., Desormeaux A., Laplante P., Vigneault N., Filep J.G., Landry K., Pshezhetsky A.V., and Hebert M.J. Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on VSMC. Faseb J. 18 (2004) 705-707
31. Roecklein B.A., and Torok-Storb B. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood 85 (1995) 997-1005
32. Rogalski T.M., Mullen G.P., Bush J.A., Gilchrist E.J., and Moerman D.G. UNC-52/perlecan isoform diversity and function in Caenorhabditis elegans. Biochem. Soc. Trans. 29 (2001) 171-176
33. Savore C., Zhang C., Muir C., Liu R., Wyrwa J., Shu J., Zhau H.E., Chung L.W., Carson D.D., and Farach-Carson M.C. Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo. Clin. Exp. Metastasis 22 (2005) 377-390
34. Tapanadechopone P., Hassell J.R., Rigatti B., and Couchman J.R. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan. Biochem. Biophys. Res. Commun. 265 (1999) 680-690
35. Thadikkaran L., Crettaz D., Siegenthaler M.A., Gallot D., Sapin V., Iozzo R.V., Queloz P.A., Schneider P., and Tissot J.D. The role of proteomics in the assessment of premature rupture of fetal membranes. Clin. Chim. Acta. 360 (2005) 27-36
36. Voigt A., Pflanz R., Schafer U., and Jackle H. Perlecan participates in proliferation activation of quiescent Drosophila neuroblasts. Dev. Dyn. 224 (2002) 403-412
37. Walsh F.S., and Doherty P. Neural cell adhesion molecules of the immunoglobulin superfamily: role in axon growth and guidance. Annu. Rev. Cell. Dev. Biol. 13 (1997) 425-456
38. Webber M.M., Bello D., and Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 1. Cell markers and immortalized nontumorigenic cell lines. Prostate 29 (1996) 286-394
39. Whitelock J.M., Murdoch A.D., Iozzo R.V., and Underwood P.A. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 271 (1996) 10079-10086
40. Yang W.D., Gomes Jr. R.R., Alicknavitch M., Farach-Carson M.C., and Carson D.D. Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds. Tissue Eng. 11 (2005) 76-89
41. Zell T., Kivens W.J., Kellermann S.A., and Shimizu Y. Regulation of integrin function by T cell activation: points of convergence and divergence. Immunol. Res. 20 (1999) 127-145